A new California law designed to bolster immunization requirements for school children has inspired at least three lawsuits, according to Capitol Weekly.

With heroin use on the rise in the region, Seattle institutions are working to develop and implement harm reduction treatments for drug addiction, according to The Daily.

Elsevier, a leading provider of medical information products and services, has improved its comprehensive drug reference tool Clinical Pharmacology by powering the service with the company's search engine ClinicalKey.

InBios International — a medical diagnostic company based in Seattle — will receive a $5.1 million boost from HHS to expedite the development of a blood test that may reduce the time for results from days to hours.

The CDC has awarded $16 million to 40 state and territory health departments to enhance rapid detection of microcephaly and other adverse outcomes linked to the Zika virus. The awarded funds are a stopgap measure and are being diverted from…

Through a 2012 audit, Hanford, Calif.-based Central Valley Network, part of Roseville, Calif.-based Adventist Health, found compliance with safe surgical attire protocols were low, and then took action to improve them.

When CMS launched its Overall Hospital Quality Star Rating program last week, hospital groups were less than pleased. One person, however, has spoken out loudly in favor of the star ratings system — Leah Binder, president and CEO of the…

The hospital-physician relationship is a delicate dance. If one steps on the other's toes, it can make or break success — particularly in an era of reform that calls for ever-closer collaboration. To learn more about what helps or hurts…

The Virginia Mason Institute, a nonprofit healthcare education organization based in Seattle, will host a workshop in Philadelphia for medical professionals on creating flow in the ambulatory setting by improving patient access, patient safety and employee satisfaction. The workshop will…

One of eight viral herpes strains known to infect humans — Epstein-Barr virus — may increase the risk of breast cancer development in some women, according to new findings published in EBioMedicine.